The epidemiology of epilepsy revisited

Current Opinion in Neurology

Volumn 16, Issue 2, 2003, Pages 165-170

  Sander, Josemir W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Epidemiology; Epilepsy; Incidence; Prevalence; Prognosis

Indexed keywords

CHRONIC DISEASE; DEVELOPED COUNTRY; DIAGNOSTIC ACCURACY; ENVIRONMENTAL FACTOR; EPILEPSY; FUTUROLOGY; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; METHODOLOGY; OUTCOMES RESEARCH; POPULATION DYNAMICS; PREDICTION; PREVALENCE; PROGNOSIS; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; SEIZURE;

AGE FACTORS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; EPILEPSY; HUMANS; INCIDENCE; PREVALENCE; PROGNOSIS; SELECTION BIAS;

EID: 0037398465     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200304000-00008     Document Type: Review

References (62)

1. Jallon P. Epilepsy and epileptic disorders, an epidemiological marker? Contributions of descriptive epidemiology. Epileptic Disord 2002; 4:1-13. This is a review of methodological problems and current knowledge in this area.
2. Sander JW, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996; 61:433-443.
3. Bell GS, Sander JW. The epidemiology of epilepsy: the size of the problem. Seizure 2001; 10:306-314.
4. Rwiza HT, Kilonzo GP, Haule J, et al. Prevalence and incidence of epilepsy in Ulanga, a rural Tanzanian district: a community-based study. Epilepsia 1992; 33:1051-1056.
5. Commission on Tropical Diseases of the International League Against Epilepsy. Relationship between epilepsy and tropical diseases. Epilepsia 1994; 35:69-93.
6. Molyneux ME. Impact of malaria on the brain and its prevention. Lancet 2000; 355:671-672.
7. Bergen DC. Preventable neurological diseases worldwide. Neuroepidemiology 1998; 17:67-73.
8. Waruiru CM, Newton CR, Forster D, et al. Epileptic seizures and malaria in Kenyan children. Trans R Soc Trop Med Hyg 1996; 90:152-155.
9. Pal DK, Carpio A, Sander JW. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000; 68:137-143.
10. Nicoletti A, Bartoloni A, Reggio A, et al. Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology 2002; 58:1256-1261. This is a most interesting study that suggests toxocariasis may be an important risk factor for partial epilepsy in resource-poor countries.
11. Anderson VE, Hauser WA, Rich SS. Genetic heterogeneity and epidemiology of the epilepsies. Adv Neurol 1999; 79:59-73.
12. Johnson MR, Sander JW. The clinical impact of epilepsy genetics. J Neurol Neurosurg Psychiatry 2001; 70:428-430.
13. Berkovic SF, Scheffer IE. Genetics of the epilepsies. Epilepsia 2001; 42 (Suppl 5):16-23. This is an authoritative review of the genetics of epilepsy with particular emphasis on ion channels.
14. Anderson E, Berkovic S, Dulac O, et al. ILAE genetics commission conference report: molecular analysis of complex genetic epilepsies. Epilepsia 2002; 43:1262-1267. This report summarizes knowledge on the complex subject of the genetics of epilepsy and makes recommendations for future research.
15. Zarrelli MM, Beghi E, Rocca WA, et al. Incidence of epileptic syndromes in Rochester, Minnesota: 1980-1984. Epilepsia 1999; 40:1708-1714.
16. MacDonald BK, Cockerell OC, Sander JW, et al. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123:665-676.
17. Kotsopoulos IA, Merode T, Kessels FG, et al. Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 2002; 43:1402-1409. This is comprehensive review and a meta-analysis of reported incidence rates for epilepsy.
18. Heaney DC, MacDonald BK, Everitt A, et al. Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ 2002; 325:1013-1016. This is the first study to show in an incident cohort that epilepsy is more likely to affect people in the more deprived segments of the population.
19. Gaitatzis A, Purcell B, Carroll K, et al. Differences in the use of health services among people with and without epilepsy in the United Kingdom: socio-economic and disease-specific determinants. Epilepsy Res 2002; 50:233-241. This study suggests that epilepsy increases comorbidity.
20. Lindsten H, Stenlund H, Edlund C, et al. Socioeconomic prognosis after a newly diagnosed unprovoked epileptic seizure in adults: a population-based case-control study. Epilepsia 2002; 43:1239-1250. This is a study of the socioeconomic impact of epilepsy in an incident cohort.
21. Placencia M, Shorvon SD, Paredes V, et al. Epileptic seizures in an Andean region of Ecuador: incidence and prevalence and regional variation. Brain 1992; 115:771-782.
22. Lavados J, Germain L, Morales A, et al. A descriptive study of epilepsy in the district of El Salvador, Chile. Acta Neurol Scand 1992; 85:249-256.
23. ILAE Commission of Epidemiology and Prognosis. The epidemiology of the Epilepsies: future directions. Epilepsia 1997; 38:614-618.
24. Everitt AD, Sander JW. Incidence of epilepsy is now higher in elderly people than children. BMJ 1998; 316:780.
25. Buntinx F, Devroey D, Van Casteren V. The incidence of stroke and transient ischaemic attacks is falling. Br J Gen Pract 2002; 52:813-817. This study shows a decrease in the incidence of stroke over the last three decades in Belgium.
26. Hallstrom B, Norrving B, Lindgren A. Stroke in Lund-Orup, Sweden: improved long-term survival among elderly stroke patients. Stroke 2002; 33:1624-1629. This study shows a considerable increase in survival in CVD.
27. Muntner P, Garrett E, Klag MJ, et al. Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of age. Stroke 2002; 33:1209-1213. This study shows an important decrease in the incidence of stroke in the USA over the last three decades.
28. Olafsson E, Hauser WA. Prevalence of epilepsy in rural Iceland: a population-based study. Epilepsia 1999; 40:1529-1534.
29. Rocca WA, Savettieri G, Anderson DW, et al. Door-to-door prevalence survey of epilepsy in three Sicilian municipalities. Neuroepidemiology 2001; 20:237-241. This study suggests a relatively low prevalence of epilepsy in Sicily.
30. Al Rajeh S, Awada A, Bademosi O, et al. The prevalence of epilepsy and other seizure disorders in an Arab population: a community-based study. Seizure 2001; 10:410-414. This study in Saudi Arabia finds prevalence rates within the expected range.
31. Gomes MM, Zeitoune RG, Kropf LA, Beeck ES. A house-to-house survey of epileptic seizures in an urban community of Rio de Janeiro, Brazil. Arq Neuropsiquiatr 2002; 60:708-711. This study in Brazil finds prevalence rates within the expected range.
32. Onal AE, Tumerdem Y, Ozturk MK, et al. Epilepsy prevalence in a rural area in Istanbul. Seizure 2002; 11:397-401. This study in Turkey finds prevalence rates within the expected range.
33. Aziz H, Ali SM, Frances P, et al. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia 1994; 35:950-958.
34. Scott RA, Lhatoo SD, Sander JW. The treatment of epilepsy in developing countries: where do we go from here? Bull World Health Organ 2001; 79:344-351.
35. Meinardi H, Scott RA, Reis R, Sander JW. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001; 42:136-149.
36. Coleman R, Loppy L, Walraven G. The treatment gap and primary health care for people with epilepsy in rural Gambia. Bull World Health Organ 2002; 80:378-383. This is an interesting account of the practical problems encountered when delivering epilepsy care in a resource-poor country.
37. Sander JW. Some aspects of prognosis in the epilepsies: a review. Epilepsia 1993; 34:1007-1016.
38. Lhatoo SD, Johnson AL, Goodridge DM, et al. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001; 49:336-344.
39. Shackleton DP, Westendorp RG, Kasteleijn-Nolst Trenite DG, et al. Survival of patients with epilepsy: an estimate of the mortality risk. Epilepsia 2002; 43:445-450. This is a study showing increased mortality amongst clinic patients in Holland.
40. Morgan CL, Kerr MP. Epilepsy and mortality: a record linkage study in a U.K. population. Epilepsia 2002; 43:1251-1255. This is a study showing increased mortality amongst clinic patients in Wales, UK.
41. Cockerell OC, Johnson AL, Sander JW, et al. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia 1997; 38:31-46.
42. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342:314-319.
43. MacDonald BK, Johnson AL, Goodridge DM, et al. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 2000; 48:833-841.
44. Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia 2001; 42:1255-1260. This is a study of the efficacy and tolerability of the first antiepileptic drug in newly diagnosed epilepsy.
45. O'Donoghue M, Sander JW. Does early anti-epileptic drug treatment alter the prognosis for remission of the epilepsies? J R Soc Med 1996; 89:245-248.
46. Hauser WA, Lee JR. Do seizures beget seizures? Prog Brain Res 2002; 135:215-219. Very challenging paper, suggesting that in some patients seizures modify brain function increasing the risk for further seizures.
47. Shinnar S, Berg AT. Does antiepileptic drug therapy alter the prognosis of childhood seizures and prevent the development of chronic epilepsy? Semin Pediatr Neurol 1994; 1:111-117.
48. Smith D, Defalla BA, Chadwick DW. The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic. Q J Med 1999; 92:15-23.
49. Lhatoo SD, Sander JW, Shorvon SD. The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11-14 years. J Neurol Neurosurg Psychiatry 2001; 71:632-637. This long-term study of AED treatment in a large incidence cohort in the UK suggests that the treatment is substandard in at least one in five.
50. Rafnsson V, Olafsson E, Hauser WA, et al. Cause-specific mortality in adults with unprovoked seizures: a population-based incidence cohort study. Neuroepidemiology 2001; 20:232-236. This is a study of the causes of death in patients with epilepsy in Iceland.
51. Camfield CS, Camfield PR, Veugelers PJ. Death in children with epilepsy: a population-based study. Lancet 2002; 359:1891-1895. This is a very important study of mortality in children with epilepsy and it shows that associated neurological disabilities are a major marker for premature death.
52. Logroscino G, Hesdorffer DC, Cascino GD, et al. Long-term mortality after a first episode of status epilepticus. Neurology 2002; 58:537-541. This is a study of long-term mortality in patients with status epilepticus in Rochester, Minnesota.
53. Sillanpaa M, Shinnar S. Status epilepticus in a population-based cohort with childhood-onset epilepsy in Finland. Ann Neurol 2002; 52:303-310. This is a study of the incidence of status epilepticus in a cohort of patients followed for over 30 years in Finland.
54. Wu YW, Shek DW, Garcia PA, et al. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 2002; 58:1070-1076. This is a study of the mortality in status epilepticus.
55. Nilsson L, Ahlbom A, Farahmand BY, et al. Risk factors for suicide in epilepsy: a case-control study. Epilepsia 2002; 43:644-651. This is an important case control study of the risk factors for suicide in people with chronic epilepsy in Sweden. Temporal lobe epilepsy was not found to be a risk factor, contrary to what is often said.
56. Walczak TS, Leppik IE, d'Amelio M, et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 2001; 56:519-525. This case control study in the USA suggests that seizure severity is the major risk factor.
57. Donner EJ, Smith CR, Snead OC. Sudden unexplained death in children with epilepsy. Neurology 2001; 57:430-434. This is the largest series of SUDEP in the paediatric age group.
58. Pedley TA, Hauser WA. Sudden death in epilepsy: a wake-up call for management. Lancet 2002; 359:1790-1791.
59. Hanna NJ, Black M, Sander JW, et al. The national sentinel clinical audit of epilepsy related death: epilepsy - death in the shadows. London: The Stationery Office; 2002.
60. Sidenvall R, Heijbel J, Blomquist HK, et al. An incident case-control study of first unprovoked afebrile seizures in children: a population-based study of pre- and perinatal risk factors. Epilepsia 2001; 42:1261-1265. Meticulous care was taken in this study with diagnostic accuracy and in carrying out standardized investigations.
61. Liu RS, Lemieux L, Bell GS, et al. A longitudinal quantitative MRI study of community-based patients with chronic epilepsy and newly diagnosed seizures: methodology and preliminary findings. Neuroimage 2001; 14:231-243. This is the first population-based study in which sophisticated magnetic resonance imaging techniques were used in the initial assessment of patients with newly diagnosed epilepsy and a control group in the community.
62. Walker MC, White HS, Sander JW. Disease modification in partial epilepsy. Brain 2002; 125:1937-1950.